APTOSE BIOSCIENCES INC (APTO)
CA03835T3091 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -51.21M | -41.82M | -65.35M | -55.24M | -26.28M | |||
| Depreciation Amortization | 88.00K | 120.00K | 150.00K | 150.00K | 610.00K | |||
| Change In Working Capital | 2.40M | 3.77M | 960.00K | -800.00K | 1.42M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 4.12M | 5.61M | 20.94M | 21.99M | 2.69M | |||
| OPERATING CASH FLOW | -44.59M | -32.32M | -43.30M | -33.89M | -21.56M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -29.00K | -20.00K | -210.00K | -80.00K | -100.00K | |||
| Other Investing Activity | 9.99M | 30.09M | -35.00M | 12.71M | -17.27M | |||
| INVESTING CASH FLOW | 9.96M | 30.07M | -35.21M | 12.63M | -17.37M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 6.91M | 120.00K | 230.00K | 58.98M | 103.89M | |||
| Other Financing Activity | N/A | N/A | N/A | -170.00K | -440.00K | |||
| FINANCING CASH FLOW | 6.91M | 120.00K | 230.00K | 58.81M | 103.45M | |||
| Exchange Rate Effect | 2.00K | 0.00 | 10.00K | 10.00K | 20.00K | |||
| CHANGE IN CASH | -27.72M | -2.13M | -78.27M | 37.56M | 64.54M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -44.59M | -32.32M | -43.30M | -33.89M | -21.56M | |||
| Capital Expenditure | -29.00K | -20.00K | -210.00K | -80.00K | -100.00K | |||
| FREE CASH FLOW | -44.62M | -32.34M | -43.51M | -33.97M | -21.66M | |||
All data in USD